Proactive Investors - Run By Investors For Investors

Rhinomed Limited gets ready to raise

Rhinomed Limited gets ready to raise

Technology firm Rhinomed Limited (ASX:RNO) has been granted a trading halt by the ASX, pending details of a capital raising.

The company has a very unique focus on nasal, respiratory and breathing management technologies, and is focussed on monetising applications for markets including sleep, wellbeing, drug delivery and sport.

Earlier in the month the company entered into a landmark partnership with SleepGP, a growing network of GP practices, to raise awareness of sleep disordered breathing issues within the family medicine setting.

Rhinomed's Mute™ is a unique nasal respiratory technology that has been found to reduce the volume and frequency of snoring in 75% of users.

The halt will remain in place until the opening of trade on Friday 18th September 2015, or earlier if an announcement is made to the market.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full RNO profile View Profile

Rhinomed Ltd Timeline

Newswire
September 15 2015

Related Articles

copd radiograph
April 02 2019
City broker Peel Hunt reckons the recent approvals “support the top-line forecasts in our model that should see Circassia achieve EBITDA positivity in 2020”
1537236236_main-better-use.jpg
September 17 2018
The company is utilising technology and big data to tackle the growing healthcare crisis and personalise treatment options for preventative care.
A stomach adenocarcinoma
February 12 2019
The company’s B-cell peptide cancer vaccines have shown promise in pre-clinical and early-stage study.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use